Skip to content

First published Friday 22 June 2018.

  • The team is looking at the application of these therapies to treat blood cancers like leukaemia and lymphoma, but Dr Foley says this kind of cellular therapy can potentially be used to treat any kind of cancer.
  • At the moment, only patients who have exhausted all conventional treatments receive immunotherapy treatments, by which stage their immune cells are usually too damaged to use. Dr Foley hopes the team’s research will show that, by bringing cellular therapy up in the treatment schedule, remarkable results are possible.
  • The first phase of clinical trials of NK cell therapy is expected to be in about four to five years.
media enquiries

Media Contacts

Please direct general enquiries to our reception on (08) 6319 1000.

Please direct media enquiries to our media team:

Tamara Hunter
Senior Communications Officer
Phone: 08 6319 1644 (office) or 0459 859 126 (mobile)
Email: Tamara Hunter

Tammy Gibbs 
Senior Communications Manager 
Phone: 08 6319 1645 (office) 0408 946 698 (mobile)
Email: Tammy Gibbs

Mailing list

Be Inspired

Join thousands of active subscribers and hear about the brave kids, dedicated researchers, and world-leading science at Telethon Kids Institute.

Lead Source:

We guarantee 100% privacy. Your information will not be shared.